Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV‐positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia
- 2 August 2007
- journal article
- clinical trial
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (8), 1054-1060
- https://doi.org/10.1111/j.1468-3083.2007.02169.x
Abstract
To evaluate the efficacy of 5% imiquimod in HIV-positive male patients with anogenital warts or anal intraepithelial neoplasia (AIN), and to elucidate whether human papillomavirus (HPV) type and viral load were important for clinical outcome and recurrences.Thirty-seven patients with histologically proven anogenital warts or AIN were enrolled. Topical 5% imiquimod was applied three times per week for more than 8 h overnight for 16 weeks, although patients were allowed to continue therapy for 4 more weeks if they did not have complete clearance of lesions.Mean age was 34 years. The perianal area was the main lesion location. Thirty-three patients had CD4 counts of < 500 cells/mm(3). Eighteen patients had a histopathological diagnosis of AIN-1. Main HPV types detected corresponded to low-risk HPV types. At 20 weeks of therapy, 46% patients achieved total clearance whereas 14 patients had > 50% clearance. Recurrence was observed in 5 of 17 patients who cleared. Clearance was not influenced by patients' CD4 counts, wart location, HIV viral load or HPV viral load.The assumption that visible perianal warts are benign lesions in HIV-positive patients has to be reevaluated since an important number of such lesions could correspond to low-grade anal disease, which in turn could progress to high-grade anal disease or cancer. In addition, our results in this preliminary study indicate that imiquimod appears to be effective in treating AIN in HIV-positive patients. Further studies are needed to document its utility to prevent high-grade dysplasia and/or anal cancer.Keywords
This publication has 29 references indexed in Scilit:
- Age-Related Prevalence of Anal Cancer Precursors in Homosexual Men: The EXPLORE StudyJNCI Journal of the National Cancer Institute, 2005
- Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infectionJournal of the American Academy of Dermatology, 2005
- Anal Intraepithelial Neoplasia in Heterosexual and Homosexual HIV?Positive Men with Access to Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Anal carcinomaAIDS, 2004
- Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% creamJournal of the American Academy of Dermatology, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patientsAIDS, 1999
- The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRJournal of General Virology, 1995
- Anal Human Papillomavirus Infection Among Homosexual and Bisexual MenSexually Transmitted Diseases, 1995
- Human Papillomavirus Infection of the CervixObstetrics & Gynecology, 1992